| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 01/02/2013 | EP2539342A1 Pyrazolopyrimidine compounds and their use as pde10 inhibitors |
| 01/02/2013 | EP2539341A1 Derivatives of 1-phenyl-1,5-dihydro-benzo[b][1.4]diazepine-2.4-dione as inhibitors of hiv replication |
| 01/02/2013 | EP2539340A1 Pyrazolopyridazine derivatives for the treatment of hepatitis c |
| 01/02/2013 | EP2539322A1 Inhibitors of beta-secretase |
| 01/02/2013 | EP2182949B1 (2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of use thereof |
| 01/02/2013 | CN102858779A Cyclic tetrapeptides and therapeutic applications thereof |
| 01/02/2013 | CN102858778A Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes |
| 01/02/2013 | CN102858777A Pyrazolopyridazine derivatives for the treatment of hepatitis C |
| 01/02/2013 | CN102858776A Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes as vasopressin V1a receptor antagonists |
| 01/02/2013 | CN102858775A Pyrrazolopyridine derivatives |
| 01/02/2013 | CN102858774A Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd |
| 01/02/2013 | CN102858773A Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd |
| 01/02/2013 | CN102858765A Pyrazolyl quinazoline kinase inhibitors |
| 01/02/2013 | CN102856564A Application of semi-porphyazine and transition metal complex thereof serving as lithium/thionyl chloride battery catalyst |
| 01/02/2013 | CN102850360A Method for preparing graphene/metal phthalocyanine compound composite material through electrostatic assembly |
| 01/02/2013 | CN102850359A Preparation method of polynuclear metal phthalocyanine alkane oxidation catalyst |
| 01/02/2013 | CN102850358A Synthesis method of tailed asymmetric porphyrin |
| 01/02/2013 | CN102850357A Preparation method of biapenem side chain compound |
| 01/02/2013 | CN102850356A Preparation method of pyrazolo[3,4-d]pyrilamine compounds |
| 01/02/2013 | CN102850349A Fused, tricyclic sulfonamide inhibitors of gamma secretase |
| 01/02/2013 | CN102850336A Derivatives of 4-piperazin-1-yl-4-benz0 [b] thiophene suitable for the treatment of cns disorders |
| 01/02/2013 | CN102850328A Pyridine chemical, its preparation method, and pharmaceutical composition containing the chemical and application thereof |
| 01/02/2013 | CN102295756B Carbazole porphyrin-thienothiadiazole copolymer as well as preparation method and application thereof |
| 01/02/2013 | CN102229612B Method for extracting chlorophyll Cu from silkworm excrements |
| 01/02/2013 | CN101296699B Pyrazolo[1,5-a]pyrimidine compounds |
| 01/02/2013 | CN101229164B Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 01/02/2013 | CN101084195B 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 01/01/2013 | US8344160 Pyrrolone melanin concentrating hormone receptor-1 antagonists |
| 01/01/2013 | US8344147 Process for preparing modulators of cystic fibrosis transmembrane conductance regulator |
| 01/01/2013 | US8344141 Pentasil-structure zeolithic material the production and use thereof |
| 01/01/2013 | US8344017 Anti-hepatitis C virus agents and anti-HIV agents |
| 01/01/2013 | US8343991 Anhydrous crystalline vinflunine salts, method of preparation and use thereof as a drug and means of vinflunine purification |
| 01/01/2013 | US8343981 Heterocyclyl-substituted dihydroquinazolines and their use as antiviral agents |
| 01/01/2013 | US8343980 Quinazoles useful as modulators of ion channels |
| 01/01/2013 | US8343977 Substituted triazolo-pyrimidine compounds |
| 01/01/2013 | US8343975 4-amino-3-(imidazolyl)-pyrazolo[3,4-D]pyrimidines |
| 01/01/2013 | US8343973 Phenoxymethyl heterocyclic compounds |
| 01/01/2013 | US8343961 Substituted heterocyclic compounds |
| 01/01/2013 | US8343956 Process for making a crystalline zilpaterol salt |
| 12/27/2012 | WO2012178125A1 Compounds useful as inhibitors of atr kinase |
| 12/27/2012 | WO2012178124A1 Compounds useful as inhibitors of atr kinase |
| 12/27/2012 | WO2012178123A1 Compounds useful as inhibitors of atr kinase |
| 12/27/2012 | WO2012177738A1 Imidazole derivatives as inhibitors of pde10 |
| 12/27/2012 | WO2012177606A1 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors |
| 12/27/2012 | WO2012176818A1 Organic electroluminescent element |
| 12/27/2012 | WO2012176575A1 Photoelectric conversion element, photoelectrochemical cell, and dye for use therein |
| 12/27/2012 | WO2012175900A1 Plasmonic junctions for surface-enhanced spectroscopy |
| 12/27/2012 | WO2012175666A1 N-oxy pyrazolo-triazepine-dione derivatives |
| 12/27/2012 | WO2012175591A1 Heterocyclyl aminoimidazopyridazines |
| 12/27/2012 | WO2012175554A1 Prodrugs of (1s,9s)-9-[[(1s)-1-carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6h-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid and their use in transdermal therapeutic systems |
| 12/27/2012 | WO2012175536A1 Dyes, method of making them, and their use in dye-sensitized solar cells |
| 12/27/2012 | WO2012135047A3 Methods and compositions for preparing noribogaine from voacangine |
| 12/27/2012 | WO2012071509A3 Benzoxazepines as inhibitors of p13k/mtor and methods of their use and manufacture |
| 12/27/2012 | WO2012065139A8 Entpd5 inhibitors |
| 12/27/2012 | WO2011135586A3 Process for the preparation of chiral beta amino carboxamide derivatives |
| 12/27/2012 | WO2011100838A9 Derivatives of l-plienyl-1.5-diliydio-benzo[b] [1.4]diazepine-2.4-dione as inhibitors of hiv replication |
| 12/27/2012 | US20120330013 Preparation method of mln4924 as an e1 activating inhibitor |
| 12/27/2012 | US20120330012 Novel Tricyclic Compounds |
| 12/27/2012 | US20120330007 Process for preparing 3-[(4s)-8-bromo-1-methyl-6-(2-pyridinyl)-4h-imidazo[1,2-a][1,4]benzodiazepine-4-yl]propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process |
| 12/27/2012 | US20120329848 Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof |
| 12/27/2012 | US20120329819 New crystalline form of pemetrexed disodium |
| 12/27/2012 | US20120329793 Substituted Imidazopyridinyl Compounds |
| 12/27/2012 | US20120329792 IMIDAZO[1,2-a]PYRAZINE DERIVATIVES AND THEIR USE FOR THE PREVENTION OR TREATMENT OF NEUROLOGICAL, PSYCHIATRIC AND METABOLIC DISORDERS AND DISEASES |
| 12/27/2012 | US20120329782 Azepine inhibitors of janus kinases |
| 12/27/2012 | US20120329780 Novel kinase inhibitors |
| 12/27/2012 | US20120329776 Heterocyclic compounds and uses thereof |
| 12/27/2012 | US20120329773 Bicyclic ring system substituted amide functionalised phenols as medicaments |
| 12/27/2012 | US20120329772 Amino-tetrazoles analogues and methods of use |
| 12/27/2012 | US20120329174 Luminescent macrocyclic lanthanide complexes |
| 12/27/2012 | US20120328569 Inhibitors of hepatitis c virus ns5b polymerase |
| 12/27/2012 | US20120328565 Antiviral compounds |
| 12/27/2012 | US20120326138 Heterocyclic compound and organic light-emitting device including the same |
| 12/27/2012 | US20120326134 Heterocyclic compound and organic light-emitting diode and flat display device including the heterocyclic compound |
| 12/27/2012 | CA2839958A1 Heterocyclyl aminoimidazopyridazines |
| 12/27/2012 | CA2839767A1 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors |
| 12/27/2012 | CA2839699A1 Trpm8 antagonists and their use in treatments |
| 12/27/2012 | CA2839628A1 N-oxy pyrazolo-triazepine-dione derivatives |
| 12/26/2012 | EP2537830A1 Compounds and compositions as protein kinase inhibitors |
| 12/26/2012 | EP2537824A1 Carbon nanoring, method for producing same, compound suitable as starting material for producing the carbon nanoring, and method for producing the compound |
| 12/26/2012 | EP2537534A1 Prodrugs of (1S,9S)-9-[[(1S)-1-carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid and their use in transdermal therapeutic systems |
| 12/26/2012 | EP2536732A2 Cyclic tetrapeptides and therapeutic applications thereof |
| 12/26/2012 | EP2536731A1 Substituted spiroindolinones |
| 12/26/2012 | EP2536730A1 Pyrrolopyrimidine compounds as inhibitors of cdk4/6 |
| 12/26/2012 | EP2536729A1 Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors |
| 12/26/2012 | EP2536728A1 Pyrazole derivatives as jak inhibitors |
| 12/26/2012 | EP2536727A1 Deuterated pyrrolopyrimidine compounds as inhibitors of cdk4/6 |
| 12/26/2012 | EP2536726A1 Diaryl ether linked pyrrolo [2,1-c][1,4]benzodiazepine hybrids and process for the preparation thereof |
| 12/26/2012 | EP2536718A1 Heterocycles as potassium channel modulators |
| 12/26/2012 | EP2536710A2 Piperidine derivatives |
| 12/26/2012 | EP2536708A2 Androgen receptor modulators and uses thereof |
| 12/26/2012 | EP2536706A1 Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same |
| 12/26/2012 | EP2536695A1 Improved processes for preparing ticagrelor intermediate, 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine |
| 12/26/2012 | EP2536279A1 Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5h -pyrimido[5,4-d][2]benzazepin-2yl]amino}-2-methoxybenzoate |
| 12/26/2012 | CN1826333B Diamine derivatives |
| 12/26/2012 | CN102844318A Compounds for treating respiratory syncytial virus infections |
| 12/26/2012 | CN102844317A Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors |
| 12/26/2012 | CN102838606A Corrosion-inhibition drag reducer for alkyl porphyrin compound natural gas pipelines and preparation method of corrosion-inhibition drag reducer |
| 12/26/2012 | CN102838605A Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes |
| 12/26/2012 | CN102838604A Heterocyclic compound and organic light-emitting device including the same |
| 12/26/2012 | CN102838603A Preparation method of intermediate compound of sitagliptin |